Kobayashi Pharmaceutical (KBYPF) Debt to Equity Ratio: 0.0034

Kobayashi Pharmaceutical Co., Ltd. (KBYPF)

39.47 0.00 (0.00%) USD | OTCM | Oct 02, 16:00

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2003. Start Trial.

Date	Value
June 30, 2026	0.0034
March 31, 2026	0.0035
December 31, 2025	0.0032
September 30, 2025	0.0033
June 30, 2025	0.0036
March 31, 2025	0.0038
December 31, 2024	0.004
September 30, 2024	0.0047
June 30, 2024	0.0055
March 31, 2024	0.0046
December 31, 2023	0.0048
September 30, 2023	0.0041
June 30, 2023	0.0042
March 31, 2023	0.0044
December 31, 2022	0.004
September 30, 2022	0.0027
June 30, 2022	0.003
March 31, 2022	0.0032
December 31, 2021	0.0032
September 30, 2021	0.0033
June 30, 2021	0.0036
March 31, 2021	0.0031
December 31, 2020	0.0038
September 30, 2020	0.0038
June 30, 2020	0.0044

Date	Value
March 31, 2020	0.0047
December 31, 2019	0.0052
September 30, 2019	0.0046
June 30, 2019	0.0051
March 31, 2019	0.0074
December 31, 2018	0.0062
September 30, 2018	0.0051
June 30, 2018	0.0052
March 31, 2018	0.0048
December 31, 2017	0.0081
September 30, 2017	0.0055
June 30, 2017	0.0055
March 31, 2017	0.0056
December 31, 2016	0.009
September 30, 2016	0.006
June 30, 2016	0.0062
March 31, 2016
March 31, 2015	0.0079
December 31, 2014	0.0009
September 30, 2014	0.0012
June 30, 2014	0.0057
March 31, 2014	0.0096
December 31, 2013	0.0016
September 30, 2013	0.0015
June 30, 2013	0.0018

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks